| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.42 MB | Adobe PDF |
Advisor(s)
Abstract(s)
Objective - Assessing the level of anxiety in oncology patients who underwent (18)F-FDG PET/CT low dose scan and identifying the main reasons that generate anxiety. Material and Method - The study included 81 cancer patients submitted to the (18)F-FDG PET/CT low dose scan. Patients filled in the Scan Experience Questionnaire and the State-Trait Anxiety Inventory (STAI) before and after (18)F-FDG PET/CT low dose scan. Results - Substantial levels of anxiety were detected both before and after (18)F-FDG PET/CT low dose scan (STAI mean > 30), with a significant increase in the state of anxiety after scan performance (p < 0.0001, Medianpre = 31.1, and Medianpos = 33.0). (18)F-FDG PET/CT low dose results are the main cause of anxiety both before (79.1%) and after (86.9%) the scan. The information provided by staff both before and on the (18)F-FDG PET/CT low dose day was classified mostly as completely understandable (70.5% and 75.3%, resp.) and as very useful (70.5% and 72.6%, resp.) and correlated positively with patients' overall satisfaction with NM Department (rS = 0.372, p = 0.004 and rS = 0.528, p = 0.000, resp.), but not with anxiety levels. Conclusions - Patients perceive high levels of anxiety during the (18)F-FDG PET/CT low dose scan and the concern with scan results was pointed out as the main factor for that emotional reaction.
Description
Keywords
Oncology Cancer patient Nuclear medicine 18F-FDG PET/CT Anxiety
Citation
Grilo A, Vieira L, Carolino C, Oliveira C, Pacheco C, Alonso J, et al. Anxiety in cancer patients during 18F-FDG PET/CT low dose: a comparison of anxiety levels before and after imaging studies. Nurs Res Pract. 2017;2017:ID3057495.
Publisher
Hindawi Publishing Corporation